Immatics (IMTX) Retained Earnings (2019 - 2025)
Immatics' (IMTX) quarterly Retained Earnings came in at -$10.0 million in Q4 2025, down 1007.8% year-on-year from $1.1 million in Q4 2024, and down 5.53% quarter-over-quarter from -$9.5 million in Q3 2025.
Immatics (IMTX) Retained Earnings (2019 - 2025) Analysis & Trends
Immatics has disclosed Retained Earnings across 7 years of filings, most recently posting -$10.0 million for Q4 2025.
- Retained Earnings for Q4 2025 came in at -$10.0 million, down 1007.8% year-over-year; the trailing twelve-month figure through Dec 2025 was -$10.0 million (down 1007.8% YoY), and the FY2025 annual result was -$9.7 million, down 981.11% from the prior year.
- Retained Earnings came in at -$10.0 million for Q4 2025 at Immatics, down from -$9.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.1 million in Q4 2024 to a low of -$692.2 million in Q3 2024.
- The 5-year median for Retained Earnings is -$4.8 million (2022), against an average of -$128.2 million.
- Peak annual rise in Retained Earnings reached 162.59% in 2024, while the deepest fall reached 89207.76% in 2024.
- Immatics' Retained Earnings stood at -$615.2 million in 2021, then rose by 15.41% to -$520.4 million in 2022, then surged by 99.66% to -$1.8 million in 2023, then surged by 162.59% to $1.1 million in 2024, then plunged by 1007.8% to -$10.0 million in 2025.
- The last three Retained Earnings figures came in at -$10.0 million (Q4 2025), -$9.5 million (Q3 2025), and -$8.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -10.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.00 Mn |
| Sep 30, 2025 | -9.48 Mn |
| Jun 30, 2025 | -8.50 Mn |
| Mar 31, 2025 | -1.77 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | -692.20 Mn |
| Jun 30, 2024 | -673.05 Mn |
| Mar 31, 2024 | -1.41 Mn |
| Dec 31, 2023 | -1.76 Mn |
| Sep 30, 2023 | -775,076.42 |
| Jun 30, 2023 | -1.24 Mn |
| Mar 31, 2023 | -984,254.45 |
| Dec 31, 2022 | -520.44 Mn |
| Sep 30, 2022 | -2.84 Mn |
| Jun 30, 2022 | -2.78 Mn |
| Mar 31, 2022 | -3.80 Mn |
| Dec 31, 2021 | -615.24 Mn |
| Sep 30, 2021 | -5.76 Mn |
| Jun 30, 2021 | -7.39 Mn |
| Mar 31, 2021 | -5.71 Mn |